...
首页> 外文期刊>Current opinion in anaesthesiology >Anaesthesia for noncardiac surgery in the heart transplant recipient.
【24h】

Anaesthesia for noncardiac surgery in the heart transplant recipient.

机译:心脏移植接受者的非心脏手术麻醉。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: Anaesthetizing a patient who benefited from a heart transplant will undoubtedly fascinate any anaesthetist. Basic principles need to be adhered to in order to ensure that no unnecessary harm is caused to these patients. Furthermore, the conscientious anaesthetist will want to remain abreast of the advances in the understanding of physiological changes occurring over the years after transplantation and the continuous innovations in the field of immunosuppression. RECENT FINDINGS: Understanding of the mechanisms surrounding cardiac allograft vasculopathy and insight into the possibility of reinnervation are continuously evolving; but changes in therapeutic regimens in an attempt to lower side effects have probably a greater impact on day-to-day clinical practice. CONCLUSION: Understanding how to administer fluids adequately to a transplant patient; how to use direct vasoactive agents; how to manage the infectious risk; and the need to be aware of the multiple side effects of immunosuppressive regimens are essential to recognize, prevent or treat possible perioperative complications.
机译:审查目的:对受益于心脏移植的患者进行麻醉无疑会使任何麻醉师着迷。需要遵守基本原则,以确保不会对这些患者造成不必要的伤害。此外,尽职尽责的麻醉师将希望与对移植后数年发生的生理变化以及免疫抑制领域的不断创新的了解保持同步。最近的发现:对心脏同种异体移植血管病周围机制的理解以及对再神经化可能性的认识正在不断发展。但是为了降低副作用而改变治疗方案可能会对日常临床实践产生更大的影响。结论:了解如何对移植患者充分使用液体;如何使用直接血管活性剂;如何管理传染风险;认识到免疫抑制方案的多种副作用对于识别,预防或治疗可能的围手术期并发症至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号